Increased methylation and decreased expression of homeobox genes TLX1, HOXA10 and DLX5 in human placenta are associated with trophoblast differentiation by Novakovic, B. et al.




Boris Novakovic, Thierry Fournier, Lynda K. Harris, Joanna James, Claire T. Roberts, Hannah E. J. 
Yong, Bill Kalionis, Danièle Evain-Brion, Peter R. Ebeling, Euan M. Wallace, Richard Saffery and Padma 
Murthi 
Increased methylation and decreased expression of homeobox genes TLX1, HOXA10 and DLX5 in 
human placenta are associated with trophoblast differentiation 
Scientific Reports, 2017; 7(1):4523-1-4523-13 
© The Author(s) 2017. Open Access This article is licensed under a Creative Commons Attribution 4.0 
International License, which permits use, sharing, adaptation, distribution and reproduction in any 
medium or format, as long as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons license, and indicate if changes were made. The images or 
other third party material in this article are included in the article’s Creative Commons license, unless 
indicated otherwise in a credit line to the material. If material is not included in the article’s Creative 
Commons license and your intended use is not permitted by statutory regulation or exceeds the 
permitted use, you will need to obtain permission directly from the copyright holder. To view a copy 
of this license, visit http://creativecommons.org/licenses/by/4.0/. 





























1Scientific RepoRts | 7: 4523  | DOI:10.1038/s41598-017-04776-5
www.nature.com/scientificreports
Increased methylation and 
decreased expression of homeobox 
genes TLX1, HOXA10 and DLX5 
in human placenta are associated 
with trophoblast differentiation
Boris Novakovic1, Thierry Fournier2,3,4, Lynda K. Harris  5, Joanna James6, Claire T. Roberts7, 
Hannah E. J. Yong8, Bill Kalionis8, Danièle Evain-Brion2,3,4, Peter R. Ebeling9, Euan M. 
Wallace  10,11, Richard Saffery  1,12 & Padma Murthi  8,9,10
Homeobox genes regulate embryonic and placental development, and are widely expressed in the 
human placenta, but their regulatory control by DNA methylation is unclear. DNA methylation analysis 
was performed on human placentae from first, second and third trimesters to determine methylation 
patterns of homeobox gene promoters across gestation. Most homeobox genes were hypo-methylated 
throughout gestation, suggesting that DNA methylation is not the primary mechanism involved 
in regulating HOX genes expression in the placenta. Nevertheless, several genes showed variable 
methylation patterns across gestation, with a general trend towards an increase in methylation over 
gestation. Three genes (TLX1, HOXA10 and DLX5) showed inverse gains of methylation with decreasing 
mRNA expression throughout pregnancy, supporting a role for DNA methylation in their regulation. 
Proteins encoded by these genes were primarily localised to the syncytiotrophoblast layer, and showed 
decreased expression later in gestation. siRNA mediated downregulation of DLX5, TLX1 and HOXA10 
in primary term villous cytotrophoblast resulted in decreased proliferation and increased expression 
of differentiation markers, including ERVW-1. Our data suggest that loss of DLX5, TLX1 and HOXA10 
expression in late gestation is required for proper placental differentiation and function.
The human placenta provides a critical interface between the maternal and fetal circulations during pregnancy. 
Formation of this interface is controlled by growth factors, cytokines and nuclear transcription factors. Cells 
respond to cues from growth factors and signalling molecules by either maintaining or altering their state of 
differentiation. Within cells, transcription factors play essential roles in regulating cell proliferation and differ-
entiation and this is evident in the most important placental lineage; trophoblast cells1–4. The numerous cellular 
transcription factors that control proliferation and differentiation fall into a few families based on the presence of 
conserved motifs, which include the zinc finger, leucine zipper, helix-loop-helix, helix-turn-helix and homeobox 
domains5, 6.
1Cancer and Disease Epigenetics, Murdoch Childrens Research Institute, Royal Children’s Hospital, Victoria, 
Australia. 2INSERM, UMR-S1139, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France. 3Université 
Paris Descartes, Paris, France. 4Fondation PremUp, Paris, France. 5Manchester Pharmacy School, The University 
of Manchester, Manchester, UK. 6Department of Obstetrics and Gynaecology, University of Auckland, Auckland, 
New Zealand. 7Robinson Research Institute, and Adelaide Medical School, University of Adelaide, North Adelaide, 
South Australia, Australia. 8Department of Maternal-Fetal Medicine Pregnancy Research Centre, The Royal Women’s 
Hospital, and Department of Obstetrics and Gynaecology, University of Melbourne, Victoria, Australia. 9Department 
of Medicine, School of Clinical Sciences, Monash University, Victoria, Australia. 10The Ritchie Centre, Hudson Institute 
of Medical Research, Victoria, Australia. 11Department of Obstetrics and Gynaecology, Monash University, Victoria, 
Australia. 12Department of Paediatrics, University of Melbourne, Victoria, Australia. Correspondence and requests 
for materials should be addressed to P.M. (email: padma.murthi@monash.edu)
Received: 6 September 2016
Accepted: 22 May 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 7: 4523  | DOI:10.1038/s41598-017-04776-5
The homeobox gene family plays fundamental roles in embryonic pattern formation and morphogene-
sis7–9. These genes were identified in mammals and vertebrates based on sequence homology to the genes of the 
Drosophila HOM-C complex8, 10, 11. In humans, the homeobox complex comprises 39 genes arranged in four sep-
arate chromosomal clusters; HOX A, B, C and D12–14 – together into various subfamilies based on their functional 
and structural characteristics, and these subfamilies are essential for the control of specific aspects of cellular 
growth and differentiation14.
Homeobox genes play major roles in controlling extraembryonic development of the placenta. Studies of 
homeobox genes in the human placenta initially focused on identifying homeobox genes expressed in the nor-
mal placenta and in trophoblastic cancers9, 15, 16. Subsequently, we and others identified human homeobox genes 
DLX3, DLX4, GAX, ESX1L and HLX, which play crucial roles in embryogenesis and organogenesis, as poten-
tially important in normal and pathological human placental development17–26. We showed HLX expression is 
primarily in proliferating cytotrophoblast cell types and in mesenchymal stem/stromal cells during placental 
development25, 27 and that HLX expression decreases in human idiopathic fetal growth restriction20. In cell culture 
models, we showed that HLX regulates trophoblast cell migration28. Targets of HLX included genes involved in 
cell cycle regulation and other aspects of proliferation29.
Homeobox gene DLX4 functional studies revealed this gene was a regulator of trophoblast cell apoptosis and 
had a potential role in epithelial-mesenchymal transition26, 30. With regard to homeobox gene DLX3, we showed 
its expression was localised to nuclei of proliferating villous and extravillous cytotrophoblast cells, as well as 
in nuclei within the syncytiotrophoblast layer in the human placenta17. DLX3 target genes are associated with 
trophoblast differentiation, including GATA2 and PPARG that encode GATA binding protein 2 and peroxisome 
proliferator-activated receptor γ respectively31, CGB, the beta subunit of hCG18, 32, and 3-βHSD18, 32. Finally, we 
and others have identified likely direct or indirect target genes downstream for homeobox genes that are involved 
in the regulation of endothelial functions33.
Whilst studies are progressing on growth factor regulation of homeobox genes and target gene identification 
in normal and pathological human placental development, our understanding of how external or environmental 
factors regulate homeobox gene expression in extraembryonic tissues, most likely via epigenetic mechanisms, is 
manifestly inadequate. We previously showed that DNA methylation (the most widely studied epigenetic pro-
cess) is dynamic during placental development, with genome-scale changes in methylation patterns between first 
and third trimester placenta34. Many studies have now investigated the association between DNA methylation 
and placental function, including the potential role as a mediator of placental dysfunction in adverse pregnancy 
outcomes of preeclampsia, gestational diabetes and intra uterine growth restriction35. Thus epigenetic modifi-
cations can regulate families of genes in the placenta during gestation. DNA methylation is one mechanism by 
which HOX gene expression is modulated, with several HOX gene loci showing tissue-specific DNA methylation 
patterns36, 37. Indeed, the HOX family of genes are more likely to show tissue-specific DNA methylation profiles 
compared with non-developmentally essential genes38.
In this study, we took a gene family-specific approach to determine the role of DNA methylation in regulating 
homeobox genes during placental development. Specifically, we identified homeobox genes showing an inverse 
relationship between DNA methylation and gene expression status from first to third trimester. Such genes are 
candidates for epigenetic regulation during placental development. Determining the temporal, epigenetic control 
of homeobox gene expression during placental development could provide insights into the function of these 
genes in placentation and in adverse pregnancy outcomes.
Results
Identification of differentially methylated homeobox family genes in the placenta across ges-
tation. The 35 HOXA-D family genes are located in four clusters on chromosomes 2, 7, 12 and 17, and are 
covered by 85 probes on the Infinium 27 K methylation array. Additionally we were interested in other genes con-
taining the homeo-box, based on previous associations with placental function or fetal development. The output 
of the HM27 array consists of a beta value with a range from 0–1, representing 0–100% methylation. Each probe 
(of the roughly 27,000) on the HM27 array, targets an individual CpG site in the genome, with the array designed 
in such a way that on average, each gene is targeted by 2 probes (with a range between 1 to >20 probes for certain 
genes). Using previously published methylation data34 (GEO31781) in 18 first, 10 second and 14 third trimester 
placentae we observe that for the most part HOX genes do not show change in methylation during gestation 
(Figs 1 to 4). HOXA and HOXB clusters contained several differential CpG sites (Figs 1 and 2), while HOXC and 
D clusters did not contain any (Fig. 3 and 4). Furthermore, we extended our analysis to profile HOX genes outside 
the HOXA-D families, and found that the majority of homeobox gene promoters show low methylation at first 
trimester, and remain hypo-methylated throughout gestation (Figure S1). Homeobox genes for which expression 
is potentially regulated by promoter DNA methylation were identified as those that showed a change in methyl-
ation (delta beta (Δβ)  > 0.1; p < 0.05) from first trimester to term. Two genes, HOXB9 and MSX1 (represented 
by 3 probes), showed a significant loss of methylation (Figures S1 and S2). In contrast, five genes (DLX5, TLX1, 
HOXA10, TGIF and HOXB6) showed increases in methylation over gestation (Figure S1). The most compelling 
finding was DLX5, which was represented by 5 probes that all showed the same trend towards increasing methyl-
ation with gestational age (Table S1).
DLX5 gene body methylation is associated with gene repression. The DLX5 gene was covered 
by 18 probes on the array, of which 6 probes showed significant increases in methylation from the first to third 
trimester (Fig. 5). The sites of differential methylation were spread over exon 2 and 3 of DLX5, and stretch across 
a region of about 1.7 kb. In order to determine the accessibility of this region, we looked at publically available 
ENCODE DNAseI tracks on the UCSC genome browser (Fig. 5). Representative DNAseI intensities are shown 
for several cell lines and primary cells. As expected, all tracks show open chromatin at the promoter region, and 
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several show DNAseI signal within the identified differentially methylated region (DMR). This comparison indi-
cates that DNA methylation change is occurring at a possible regulatory region.
Relationship between homeobox gene methylation and expression in placenta tissue through-
out pregnancy. DNA methylation changes (Δβ) from first to third trimester were plotted against fold expres-
sion change during the same gestation period. Expression changes were measured for 13 genes using real-time 
PCR. Overall, increasing gestation was associated with a loss of homeobox gene expression, with 11 out of 13 
homeobox genes showing lower expression in the third trimester (Fig. 6). For most genes, loss of expression was 
not associated with an increase in DNA methylation (Fig. 6A and B), suggesting that DNA methylation is not 
the primary mechanism of regulating expression of these genes. Only three genes (TLX1, HOXA10 and DLX5) 
showed a reciprocal gain of methylation with decreasing expression over time (Fig. 6A) suggesting a role for 
DNA methylation in gene regulation. Interestingly, for each of TLX1, HOXA10 and DLX5, methylation increased 
Figure 1. DNA methylation levels and dynamics at the HOXA gene cluster. (A) Location and organization of 
the HOXA gene cluster on chromosome 7, with the location of genes and HM27 probes shown. (B) Bar plot 
showing mean DNA methylation level (beta-value) for each probe located within the HOXA locus, sorted by 
gene. For first, second and third trimester, n = 18, 10, and 14 were used, respectively. Error bars are standard 
deviation. (C) Radar plot showing change in methylation (delta-Beta) for each probe within the HOXA cluster 
in second and third trimester, relative to first trimester placenta. Black line marks 0 (no change in methylation), 
positive values indicate increase in methylation and negative values indicate decrease in methylation over 
gestation.
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progressively over gestation, with second trimester showing an intermediate level of methylation to that of first 
and third trimester villi (Fig. 6C). In order to confirm that the DNA methylation changes observed at the HM27 
CpG probes were representative of the surrounding region, we used published HM450 array data on 5 first and 10 
third trimester placentas, from an unrelated cohort (GSE49343)39. We show that the HOXA10 differential probe 
is in a DMR with 5 CpG sites showing increased methylation over gestation (Figure S3). The DLX5 probes are in 
a large DMR containing 12 differential CpG probes (Figure S4) and the TLX1 probes are in a region containing 4 
differential CpG probes (Figure S5). The change in expression of DLX5, TLX1 and HOXA10 across gestation was 
investigated by quantitative RT-PCR on first, second and third trimester placental villi (Fig. 6D). These analyses 
showed a significant decrease in expression of all three genes in second trimester and third trimester placentae 
compared with first trimester placental tissues (Fig. 6D).
Figure 2. DNA methylation levels and dynamics at the HOXB gene cluster. (A) Location and organization of 
the HOXB gene cluster on chromosome 17, with the location of genes and HM27 probes shown. (B) As in Fig. 1 
legend above but for HOXB locus, sorted by gene. For first, second and third trimester, n = 18, 10, and 14 were 
used, respectively. Error bars are standard deviation. (C) As in Fig. 1 legend above but for each probe within 
the HOXB cluster in second and third trimester, relative to first trimester placenta. Black line marks 0 (no 
change in methylation), positive values indicate increase in methylation and negative values indicate decrease in 
methylation over gestation.
www.nature.com/scientificreports/
5Scientific RepoRts | 7: 4523  | DOI:10.1038/s41598-017-04776-5
DLX5, HOXA10 and TLX1 are localised in the nuclei of the syncytiotrophoblast of the 
first-trimester and term placentae. The DNA methylation and gene expression data suggest a progres-
sive silencing of DLX5, TLX1 and HOXA10 expression in placental villi during gestation. We therefore sought 
to determine the specific cell compartments to which these proteins are localised. Figure 7A demonstrates 
that DLX5, HOXA10 and TLX1 protein was localised primarily to the nuclei of syncytiotrophoblast in both 
first-trimester (Panel A–C) and term placental tissues (Panel D–F). Weaker expression of these genes was also 
detected in the villous stroma. Non-immune rabbit IgG was used as a negative control (Panel G) and CK7 was 
used as a positive control (Panel H). Figure 7I shows the quantitative analysis of the staining intensity for DLX5, 
HOXA10 and TLX1. The staining intensity was significantly decreased in term placental tissues (n = 5) for all 
three candidate proteins compared with first-trimester placentae (n = 5).
Functional role of DLX5, HOXA10 and TLX1 in primary term trophoblasts. Figure 8 demonstrates 
the functional role of DLX5, HOXA10 and TLX1 in trophoblast proliferation, differentiation and apoptosis fol-
lowing treatment of cultured trophoblasts with specific siRNAs. Gene specific siRNA treatment of trophoblasts 
Figure 3. DNA methylation levels and dynamics at the HOXC gene cluster. (A) Location and organization of 
the HOXC gene cluster on chromosome 12, with the location of genes and HM27 probes shown. (B) As in Fig. 1 
legend above but for HOXC locus, sorted by gene. (C) As in Fig. 1 legend above but for HOXC cluster. Black 
line marks 0 (no change in methylation), positive values indicate increase in methylation and negative values 
indicate decrease in methylation over gestation.
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significantly decreased DLX5 (Fig. 8A), HOXA10 (Fig. 8D) and TLX1 (Fig. 8G) relative to 18S rRNA compared 
with siCONT (scrambled control) treated cells (n = 4 independent experiments, p < 0.05). Functional analyses 
of trophoblasts demonstrated a reduction in cellular proliferation following treatment with siDLX5 (Fig. 8B), or 
siHOXA10 (Fig. 8E), or siTLX1 (Fig. 8H) compared with siCONT treated trophoblasts (n = 4 independent exper-
iments, p < 0.05). Furthermore, CGB, ERW-1 (Syncytin-1) and TP53 mRNA were also significantly increased 
following treatment with siDLX5 (Fig. 8C), or siHOXA10 (Fig. 8F), or siTLX1 (Fig. 8I) compared with siCONT 
treated trophoblasts suggesting that markers of trophoblast differentiation and apoptosis are direct or indirect 
targets of DLX5, HOXA10 and TLX1.
Discussion
In this study, we report differential methylation of homeobox genes in the human placenta across gestation. 
Interestingly, our data reveal that the majority of homeobox gene promoters are hypo-methylated during the 
first trimester and remain so throughout gestation (Figs 1 to 4 and S1). This indicates that many homeobox gene 
Figure 4. DNA methylation levels and dynamics at the HOXD gene cluster. (A) Location and organization 
of the HOXD gene cluster on chromosome 2, with the location of genes and HM27 probes shown. (B) As in 
Fig. 1 legend above but for HOXD locus, sorted by gene. (C) As in Fig. 1 legend but for each probe within the 
HOXD cluster in second and third trimester, relative to first trimester placenta. Black line marks 0 (no change 
in methylation), positive values indicate increase in methylation and negative values indicate decrease in 
methylation over gestation.
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promoters remain open, allowing the induction of these genes in the placenta at all stages of pregnancy. This 
may be important, as throughout gestation the placenta must maintain its fundamental roles of active nutrient 
transport between the maternal and fetal circulations, protecting the fetus from maternal immune rejection, and 
producing and secreting hormones and growth factors. Homeobox genes have been implicated in regulating these 
processes. Nevertheless, expression analysis shows that all but two genes have loss of expression over gestation, 
indicating that expression of homeobox genes peaks in the first trimester (Fig. 6).
We previously showed wide-spread changes in genome-wide promoter methylation in the human placenta 
over gestation34. Overall promoter methylation alone was predictive of gestational age, and several hundred pro-
moters showed significant DNA methylation changes between first and third trimester. A general increase in 
promoter methylation was observed, suggesting that early gestation is associated with a higher capacity for gene 
induction. In this study, we sought to investigate the role of DNA methylation in controlling homeobox gene 
expression in the placenta throughout gestation.
Several homeobox genes became increasingly methylated during gestation, with one or more HM27 probes 
showing differential methylation. We chose to further explore the role of three genes, DLX5, HOXA10 and TLX1, 
in placental function, based on significant change in DNA methylation at these genes (Table S1), and an inverse 
correlation between DNA methylation and level of expression over gestation. The largest DMR was found within 
the gene body of the homeobox gene DLX5 (distal-less homeobox 5), with 5 CpG sites within the region showing 
progressively higher expression in 2nd and 3rd trimesters compared to first trimester villi (Fig. 5). This change in 
methylation correlated with decreased DLX5 transcription (Fig. 6A). The specific role of DLX5 in the human 
placenta, and the purpose of increased DLX5 methylation during gestation are not yet known. In a recent study 
of known and putative imprinted genes in the human placenta, the transcription factor DLX5 was one of 10 genes 
that could discern between newborn neurobehavioural profiles deduced from the Network Neurobehavioural 
Scales40. These data suggested that control of DLX5 expression in the placenta by methylation may be important 
for neurobehavioural development. Although the relationship between gene body DNA methylation and gene 
expression control is not always easy to deduce, it is becoming increasingly clear from numerous sources that 
many gene enhancer elements in the introns of genes can interact with promoters to regulate gene transcription. 
Based on publically available ENCODE DNAseI tracks, we show that the 1.7 kb region with increased DNA 
Figure 5. DLX5 gene body methylation is restricted to the 3′ end DLX5 had the highest number of associated 
dynamic CpG sites. By plotting DNA methylation in first, second and third trimester for each site at this gene, 
it is clear that DNA methylation change is occurring at the 3′ end of the gene, and not at the promoter region. 
ENCODE DNAseI track shows that the 3′ DMR is associated with open chromatin in a subset of human tissues, 
indicating that change in DNA methylation may result in change of accessibility.
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Figure 6. Effect of DNA methylation change at homeobox gene loci on gene expression. (A) The correlation between 
DNA methylation change between first and third trimester (y-axis) and RNA expression change between first and 
third trimester (x-axis) for each homeobox gene. Eleven out of 13 genes showed lower expression in third trimester 
compared to first (clustering left of centre). Only 3 genes - DLX5, HOXA10 and TLX1 showed a concomitant increase 
in methylation (clustering in top left corner). (B) Shows the magnified view of the boxed area in panel A. DNA 
methylation data points represent n = 18 first trimester and n = 10 third trimester samples, while gene expression 
data points represent n = 5 first trimester and n = 2 third trimester samples. (C) Change in DNA methylation in 
second and third trimester compared to first trimester for DLX5 (HM27 probe cg00503840), HOXA10 (HM27 probe 
cg00518911), TLX1 (HM27 probe cg11498156). The second trimester shows an intermediate level of methylation 
change compared to third trimester, which indicates that DNA methylation is changing progressively over gestation. 
The change in methylation at second or third trimester is based on the difference between the mean methylation 
of these time-points relative to the first trimester time-point (delta Beta). (D) Quantitative RT-PCR confirms the 
reduction in TLX1, HOXA10 and DLX5 expression during gestation. N = 12 first trimester, n = 4 second trimester, 
and n = 6 third trimester, data are presented as relative expression change (mean+/− SD).
www.nature.com/scientificreports/
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methylation within the DLX5 gene is associated with open chromatin. Therefore, DLX5 gene body methylation 
may be located at a regulatory element of the gene, which requires further investigation (Fig. 5).
Another potential role for DLX5 methylation may be in regulating stem cell function. The murine homologue, 
Dlx5, plays a crucial role in the commitment of bone marrow mesenchymal stem cells (MSCs) into osteoblasts 
and adipocytes41. In the human placenta, we showed that DLX5 is localised to nuclei of cells within the predicted 
vascular niche of chorionic mesenchymal stem/stromal cells (CMSC). Furthermore, DLX5 nuclear expression 
was also detected in cultured first trimester CMSC, and there was a qualitative decrease in DLX5 expression in 
cultured, term CMSC. Cultured CMSC are capable of differentiating into the mesenchymal lineages including 
osteoblasts and adipocytes27. In a recent study, evidence was provided that DLX5 is a regulator of human bone 
marrow MSC osteogenic differentiation and that DLX5 expression was not associated with a change in DNA 
methylation level. The authors concluded that the low to partial level of methylation at the CpG island is consist-
ent with the ability of the gene to be induced42. Due to the approach used, the authors of that study were only able 
to interrogate a region of 150 bp, while the distribution of the probes on the HM27 platform allowed us to identify 
that the DMR is about 1.7 kb in length. At the 5′ end of the CpG Island the methylation level was indeed low and 
showed only a slight increase in methylation, while at the 3′ end, the methylation change was higher.
Two other genes - HOXA10 and TLX1 also showed a significant decrease in RNA expression in second trimes-
ter and third trimester placentae compared with first trimester placentae (Fig. 6C), accompanied by higher DNA 
methylation (Fig. 6D). The concordant change in DNA methylation and gene expression indicated that these 
genes are regulated during gestation, and may have roles in placental development and function. Next, we deter-
mined that within the placental villi, DLX5, HOXA10 and TLX1 protein were localised primarily to the nuclei 
of syncytiotrophoblast, as well as in stromal cells of both first-trimester and term placentae. Nuclear localisation 
was consistent with DLX5, HOXA10 and TLX1 acting as nuclear transcription factors (Fig. 7). Furthermore, a 
decrease in the staining intensity for DLX5, HOXA10 and TLX1 protein was observed using immunohistochem-
ical analysis of term placental tissues compared with first trimester placentae (Fig. 7I). This data, were consistent 
Figure 7. Localisation of DLX5, HOXA10 and TLX1 proteins in first and third trimester placentae 
Representative sections of n = 5 first trimester and n = 5 third trimester placentae. DLX5, HOXA10 and TLX1 
are expressed in the syncytiotrophoblast layer (black arrows) of first trimester (A–C) and third trimester 
(D–F) placentae. CK7 was used as a positive marker (H) and IgG as a negative control (G). (I) Dot plot shows 
immunoreactive signal pixel density for DLX5, HOXA10 and TLX1 in first and third trimester villi. Intensity for 
all three candidate proteins was significantly lower in the third trimester. The intensity of staining was calculated 
using an AxioVision software (Carl Zeiss KS 400, Germany) from five fields of view of each placental section 
and the results were expressed as the mean pixel density (in arbitrary units). Str = stromal.
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with the decreased mRNA expression and associated increased DNA methylation across gestation for the can-
didate genes (Fig. 6C and D). The localisation of these genes to the syncytiotrophoblast later suggests that their 
decreased expression influences the function of the syncytiotrophoblast, or in the differentiation of trophoblasts.
By using siRNAs specific for DLX5, HOXA10 and TLX1, we showed that down-regulation of these genes in 
primary trophoblasts leads to loss of proliferation, and an increase in mRNA expression of differentiation mark-
ers, such as ERVW-1 (Fig. 8). This suggests that loss of these proteins is required for proper syncytiotrophoblast 
development during gestation. Interestingly, loss of these genes at the second trimester stage onwards, correlates 
well with the reported increase in ERVW-1 expression in the second and third trimester, relative to early preg-
nancy43. In conclusion, our studies demonstrated that the homeobox gene methylation and their transcription are 
important for normal placental development. Furthermore, it is important to determine whether the increased 
DLX5, TLX1 or HOXA10 methylation and decreased transcription observed during normal placentation are 
altered in placental pathologies.
Methods and Materials
Collection of placental tissues. First trimester placentae (6–12 weeks gestation) were obtained following 
elective terminations of pregnancy. Term placentae (37–42 weeks gestation) were obtained from uncomplicated 
pregnancies within 30 min of vaginal or Caesarean delivery. All patients provided written informed consent. 
Ethical approval was granted by the Committee on Clinical Investigation, Broussais Hospital (Paris, France), 
North West Local Research Ethical Committee, St. Mary’s Hospital (Manchester, UK), Auckland Medical Aid 
Centre (AMAC), Auckland (New Zealand) and with the approval from the Northern Health and Disability 
Ethics Committee (NTX1206067AM05), CYWHS Human Research Ethics Committee (REC2249/2/13) North 
Adelaide Australia, Monash Health Human Research and Ethics Committee (Clayton, Melbourne) and The Royal 
Women’s Hospital Human Research and Ethics Committee (Melbourne, Australia) and the study was performed 
Figure 8. Reduction of DLX5, HOXA10 and TLX1 expression in trophoblasts using siRNA leads to lower 
proliferation and higher expression of differentiation markers siRNA specific for DLX5, HOXA10 and TLX1 
were used to knock-down their expression in primary trophoblasts. Expression of DLX5 (A), HOXA10 (D) and 
TLX1 (G) were reduced by the siRNA. In each case, trophoblast proliferation was reduced (panels B, E, and H). 
Reduction in DLX5, HOXA10 or TLX1, resulted in increased expression of trophoblast differentiation markers 
- CGB, ERVW-1 and TP53 (panels C, F, and I). For panels B, E and H, @495 nm = absorbance at 495 nm.
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in accordance with the relevant guidelines and regulations. Villous tissue was randomly sampled and snap fro-
zen for RNA and DNA extractions. For immunohistochemical analyses villous tissue was washed in PBS, fixed 
in neutral buffered formalin (4% (v/v)) for 24 h and embedded in paraffin wax. In total 18 first, 10 second and 
14 third trimester villous samples were used for HM27 array analysis. For gene expression and immunohisto-
chemical analysis, 12 first, 4–6 second and 6 third trimester villi preparations were used. For isolation of villous 
cytotrophoblasts, term placentae were collected from Caesarean delivery of uncomplicated pregnancies (n = 4).
DNA extraction. DNA was extracted as previously described34, 44–46. Tissue samples were incubated at 50 °C 
overnight with shaking in DNA extraction buffer (100 mM NaCl, 10 mM Tris-HCl (pH 8.0), 25 mM EDTA, 0.5% 
(w/v) SDS), containing 200 mg/ml proteinase K. DNA was isolated by two rounds of phenol: chloroform extrac-
tion, followed by RNAse A treatment. DNA was precipitated in absolute ethanol containing 10% (v/v) sodium 
acetate (3 M, pH 5.2), and resuspended in 100 ml nuclease-free water (Ambion, Austin, TX, USA). DNA was 
stored at −20 °C until needed.
DNA methylation array analysis. We previously performed genome-scale DNA methylation analysis on 
18 first (8–12 weeks), 10 second (17–24 weeks) and 14 third trimester placental (34–41 weeks) samples, using 
the Illumina Infinium Human-Methylation27 BeadChip (HM27)34. For this study, data were exported from 
Gene Expression Omnibus, accession number GSE31781 to analyse the methylation status of homeobox genes. 
Methylation values for specific homeobox genes were extracted and analysed for significant changes using R 
(https://cran.r-project.org/) and Excel.
Gene expression analysis by quantitative real time PCR (RT-PCR). Relative quantitation of mRNA 
in placental tissues was performed in an ABI Prism 7500 using Applied Biosystems inventoried assays (Foster 
City, CA, USA). The assay mix consisted of unlabelled PCR primers and a TaqMan FAM-labelled MGB probes 
for DLX5 (Hs01573641_mH); HOXA10 (Hs00172012_m1); TLX1 (Hs00271457_m1); CGB (Hs01668436_g1); 
syncytin-1/ERVW-1 (Hs01926764_u1) and TP53 (Hs01034249_m1), (Thermo Fisher Scientific, Waltham, 
MA, USA). Gene expression relative to 18S rRNA (4319413E, VIC/MGB probe, primer limited, Thermo Fisher 
Scientific, Waltham, MA, USA) was calculated according to the 2−ΔΔCT method47. In total n = 5 first trimester, 
n = 3 second trimester and n = 2 third trimester samples were profiled for gene expression of a panel of genes. 
Additionally, DLX5, HOXA10 and TLX1 expression were confirmed in additional n = 12 first, n = 4 second and 
n = 4 third trimester samples.
Immunohistochemistry. Sections (5 µm) of wax-embedded placenta were deparaffinised in Histoclear and 
alcohol and microwaved at full power for 10 min in sodium citrate buffer (0.01 M; containing 0.05% (v/v) Tween 
20, pH 6.0) to facilitate antigen unmasking. After cooling for 20 min, sections were washed in distilled water 
and endogenous peroxide activity was quenched by incubation with 3% (v/v) hydrogen peroxide at room tem-
perature for 10 min. Tissue sections were washed (3 × 5 min) in 0.05 M Tris buffered saline (TBS) and blocked 
with 5% (w/v) BSA in TBS for 30 min. Primary antibodies, diluted to the required concentration with 5% (w/v) 
BSA solution [rabbit polyclonal DLX5 EPR4488 antibody 1:500, HOXA10 Ab191470 antibody, 1:750 and TLX1 
Ab78498 antibody (Abcam, Cambridge, UK); mouse monoclonal cytokeratin-7 antibody 1:100 (Dako, Glostrup, 
Denmark) and control rabbit IgG (concentration matched, Sigma-Aldrich, St Louis, MO, USA)] were applied to 
the tissue sections, which were incubated overnight at 4 °C in a humidity chamber. Slides were washed in TBS 
(3 × 5 min) and the secondary antibodies, diluted in TBS (biotinylated rabbit anti-goat IgG 1:500; biotinylated 
goat anti-mouse IgG 1:200, Dako, Glostrup, Denmark), were applied for 30 min at room temperature. Slides were 
washed again (TBS; 3 × 5 min) and incubated with avidin peroxidase (5 μg/ml; Sigma-Aldrich, St Louis, MO, 
USA) for 30 min at room temperature. After further TBS washes (3 × 5 min), tissue sections were incubated with 
0.05% (w/v) 3,3′-diaminobenzidine (DAB) and 0.015% (v/v) hydrogen peroxide (Sigma-Aldrich, St Louis, MO, 
USA) and colour development was monitored under a light microscope. Slides were washed in distilled water, 
counterstained with hematoxylin, rehydrated in alcohol and Histoclear, and mounted in DPX (Sigma-Aldrich, 
St Louis, MO, USA) for imaging with a Leitz Dialux22 light microscope (Stuggart, Germany). All tissue sections 
were incubated with DAB for the same length of time so that comparisons could be made between individual 
samples, and all slides were stained in a single run to eliminate inter-experimental variations in staining intensity. 
Exposure times and background colour were matched at image capture. The intensity of staining was calculated 
using the AxioVision software (Carl Zeiss, Oberkochen, Germany) from five fields of view of each placental sec-
tion and the results are expressed as the mean pixel density (in arbitrary units).
Villous cytotrophoblast isolation, culture and siRNA treatment. Villous cytotrophoblasts (VCTs) 
were prepared from placentae obtained from uncomplicated term pregnancies as described previously31. Briefly, 
VCTs were enriched by differential sequential trypsin digestion and the use of a Percoll gradient (20–60%). VCTs 
were plated at a density of 1.0 × 104 cells/cm2 in 6-well tissue culture plates using DMEM supplemented with 10% 
fetal bovine serum (FBS), 2 mM glutamine, 100 µg/mL streptomycin, 100 IU/mL penicillin. The purity of VCT 
cultures was characterised by positive staining for CK7 (95% positive cells) and by microscopic observation of cell 
aggregates and syncytiotrophoblast formation at 48 to 72 hours. VCT were seeded at a density of 0.5 × 105 cells/
well in 24-well plates and transfected with Thermo Fisher Scientific (Waltham, MA, USA) DLX5 siRNA (siDLX5) 
or HOXA10 siRNA (siHOXA10) or TLX1 siRNA (siTLX1), using the HiPerFect transfection reagent (Qiagen, 
Hilden, Germany). The optimum siRNA: HiPerFect ratio and incubation time for the culture was determined 
to be 1:6 and 72 h, respectively (data not shown). Negative control siRNA (siCONT) used in these experiments 
consisted of an enzyme-generated pool of oligonucleotides (15–19 base pairs) that showed no DNA sequence 
similarity to any known human gene (AllStars Neg. siRNA AF 488, Qiagen, Hilden, Germany)31. At the end of the 
www.nature.com/scientificreports/
1 2Scientific RepoRts | 7: 4523  | DOI:10.1038/s41598-017-04776-5
incubation, the cells were collected for analysis of gene expression for DLX5, HOXA10, TLX1, and trophoblast 
differentiation markers CGB, ERVW-1 and apoptosis marker, TP53.
Cell proliferation assay. VCTs were grown in 96-well plate (2 × 104 cells/well, Corning) for 24 h. Following 
siDLX5/siHOXA10/siTLX1 or siCONT treatment of trophoblasts, the proliferation potential of cells was deter-
mined using the CellTiter 96® AQueous One Solution Cell Proliferation assay (Promega Corporation, Madison, 
WI, USA) and the absorbance at 490 nm was recorded using an ELISA plate reader (SpectraMax i3).
Statistical analyses. A p-value of <0.05 was considered statistically significant. The LIMMA package was 
used for HM27 DNA methylation analysis, and probes were considered significant based on an adjusted p-value 
(Benjamini correction).
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